1. Comparison of clinical parameters with whole exome sequencing analysis results of autosomal recessive patients; a center experience
- Author
-
Kamuran Avci, Muhsin Elmas, Mustafa Solak, Mujgan Ozdemir Erdogan, Handan Yildiz, and Basak Gogus
- Subjects
Male ,0301 basic medicine ,Heterozygote ,Microcephaly ,Adolescent ,Consanguinity ,Disease ,03 medical and health sciences ,0302 clinical medicine ,Genotype-phenotype distinction ,Intellectual Disability ,Exome Sequencing ,Intellectual disability ,Genetics ,medicine ,Humans ,Exome ,In patient ,Child ,Molecular Biology ,Genetic Association Studies ,Exome sequencing ,Retrospective Studies ,Pathogenic mutation ,business.industry ,Homozygote ,Sequence Analysis, DNA ,General Medicine ,medicine.disease ,Pedigree ,030104 developmental biology ,Child, Preschool ,030220 oncology & carcinogenesis ,Mutation ,Female ,business - Abstract
Whole-exome sequencing (WES) is an ideal method for the diagnosis of autosomal recessive diseases. The aim of this study was to evaluate the diagnostic power of WES in patients with autosomal recessive inheritance and to determine the relationship between genotype and phenotype. Retrospective screenings of 24 patients analysed with WES were performed and clinical and genetic data were evaluated. Any pathogenic mutation that could explain the suspected disease in 4 patients was not identified. A homozygous pathogenic mutation was detected in 18 patients. 2 patients had heterozygous mutations. According to this study results, WES is a successful technique to be used at the stage of diagnosis in patients who are accompanied by various degrees of intellectual disability matching the inheritance of the autosomal recessive.
- Published
- 2018
- Full Text
- View/download PDF